伦瓦提尼
癌症研究
基因敲除
肝细胞癌
医学
生物
索拉非尼
细胞凋亡
生物化学
作者
Peihong Zhang,Shiping Chen,Jialiang Cai,Lina Song,Bing Quan,Jing-Lei Wan,Gui‐Qi Zhu,Biao Wang,Yi Yang,Zheng‐Jun Zhou,Tao Li,Zhi Dai
标识
DOI:10.1007/s13402-024-01032-7
摘要
GALNT6 is integral to the resistance mechanisms against lenvatinib in HCC by modulating autophagy and CAF activation. Targeting GALNT6 offers a promising strategy to enhance lenvatinib efficacy and improve therapeutic outcomes in HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI